Spots Global Cancer Trial Database for peripheral neuropathy
Every month we try and update this database with for peripheral neuropathy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | NCT03098589 | Lymphoma | Revlimid | 18 Years - | Celgene | |
Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients | NCT03430674 | Peripheral Neur... | Exercise | 5 Years - 18 Years | Indiana University | |
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy | NCT04201561 | Chemotherapy-in... Recurrent Ovari... Ovarian Cancer Fallopian Tube ... Primary Periton... | sodium selenite... Normal saline Chemotherapy | 19 Years - 80 Years | Seoul National University Hospital | |
Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer | NCT05663723 | Peripheral Nerv... | Intervention gr... Intervention gr... Control group w... | 18 Years - | Instituto Nacional de Cancer, Brazil | |
Acupuncture for Chemotherapy-induced Peripheral Neuropathy | NCT01892852 | Peripheral Neur... Toxicity Due to... Lymphoma Multiple Myelom... | Acupuncture | 18 Years - | Pusan National University Hospital | |
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy | NCT00267007 | Peripheral Neur... | PROCRIT 40,000 ... Placebo | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
Cryotherapy & Oxaliplatin | NCT06281925 | Colon Cancer Peripheral Neur... | Cryotherapy Glo... | 18 Years - | NYU Langone Health | |
Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy | NCT01569269 | Peripheral Neur... | Yoga Interventi... Meditation Inte... Reiki Holistic Educat... | 18 Years - 90 Years | George Mason University | |
EXercise Influence on Taxane Side Effects (EXIT) Study | NCT02473861 | Breast Neoplasm... | Exercise | 19 Years - | University of British Columbia | |
The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life | NCT06012253 | Chemotherapeuti... | Home Based Walk... | 18 Years - | Akdeniz University Hospital | |
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy | NCT01422993 | Neuropathy Gastrointestina... | 12 Week Exercis... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Exercises for Patients Who Were Receiving Chemotherapy | NCT03798379 | Chemotherapy-in... | Exercise | 20 Years - 75 Years | Hitit University | |
Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy | NCT03065478 | CIPN in Adjuvan... CIPN in Adjuvan... | OnLife | 18 Years - | Swiss Medical Food AG | |
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients | NCT05889988 | Breast Neoplasm | 18 Years - | Mayo Clinic | ||
Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy | NCT06400849 | Non-metastatic ... | cryotherapy alo... cryotherapy and... | 18 Years - 99 Years | Centre Antoine Lacassagne | |
PT-112 in Subjects With Thymoma and Thymic Carcinoma | NCT05104736 | Thymic Epitheli... Recurrent Thymo... Thymic Cancer | PT-112 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation | NCT06199115 | Cancer of the G... | Photobiomodulat... | 18 Years - | Saint-Gregoire Private Hospital Center | |
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients | NCT00872352 | Multiple Myelom... Peripheral Neur... | EMG | 18 Years - 75 Years | Wolfson Medical Center | |
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel | NCT02297412 | Acute Pain Breast Carcinom... Peripheral Neur... | Minocycline Hyd... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy | NCT03027245 | Locally Advance... | Eribulin | 18 Years - | Eisai Inc. | |
Skin Biopsies in Chemotherapy-Induced Neuropathy | NCT00956033 | Multiple Myelom... Peripheral Neur... | 18 Years - | Erasmus Medical Center | ||
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma | NCT02362165 | Multiple Myelom... | Cyclophosphamid... Bortezomib Dexamethasone Doxorubicin | 18 Years - 80 Years | Sun Yat-sen University | |
SINF: Peripheral Neuropathy in Cancer Survivors | NCT02168894 | Peripheral Neur... | Acupuncture Nerve Function ... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
Non-interventional Study With Nab-Paclitaxel (Abraxane®) | NCT01689610 | Metastatic Brea... | 18 Years - | iOMEDICO AG | ||
Skin Biopsies in Chemotherapy-Induced Neuropathy | NCT00956033 | Multiple Myelom... Peripheral Neur... | 18 Years - | Erasmus Medical Center | ||
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities | NCT05404230 | Peripheral Neur... Colorectal Canc... | Fish oil Corn oil | 18 Years - | Vejle Hospital | |
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer | NCT02606110 | Peripheral Neur... | 18 Years - | Eastern Regional Medical Center | ||
Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) | NCT06405542 | Chemotherapy-in... | EX-CIPN | 18 Years - | University Health Network, Toronto | |
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel | NCT01243541 | Chemotherapeuti... Pain Peripheral Neur... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Therapy-related... | cryotherapy questionnaire a... quality-of-life... management of t... assessment of t... | 18 Years - | Northwestern University | |
Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib | NCT04565600 | Pain Syndrome | Etoricoxib | 18 Years - | Guangdong Provincial People's Hospital | |
Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors Patients | NCT05111730 | Peripheral Neur... | The Shock wave ... | 8 Years - 40 Years | South Valley University | |
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer | NCT02215083 | Peripheral Neur... | L-glutamine | 18 Years - | Eastern Regional Medical Center | |
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study) | NCT01278004 | Cancer Peripheral Neur... | Ethosuximide Placebo | 18 Years - | Royal Marsden NHS Foundation Trust | |
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study) | NCT01278004 | Cancer Peripheral Neur... | Ethosuximide Placebo | 18 Years - | Royal Marsden NHS Foundation Trust | |
The Inland Northwest Colon Cancer Survivor's Study | NCT01775254 | Colon Cancer | 18 Years - | Washington State University | ||
Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy | NCT02093910 | Multiple Myelom... | Monosialotetrah... | 18 Years - 80 Years | Sun Yat-sen University | |
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer | NCT03139435 | Peripheral Neur... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Biopsy Questionnaire A... Ultrasound Tomo... | - | Wake Forest University Health Sciences | |
Evaluation of Hydroxychloroquine to Prevent CIPN | NCT05689359 | Breast Cancer Gynecologic Can... Early-stage Bre... Peripheral Neur... Chemotherapy-in... | Hydroxychloroqu... | 21 Years - | University of Arizona | |
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer | NCT02428101 | Gastrointestina... Peripheral Neur... | polymorphism an... | 18 Years - 80 Years | Ain Shams University | |
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients | NCT01697839 | Multiple Myelom... Peripheral Neur... | 18 Years - | Oncotherapeutics | ||
Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) | NCT06405542 | Chemotherapy-in... | EX-CIPN | 18 Years - | University Health Network, Toronto | |
Chemotherapy - Induced Peripheral Neuropathy | NCT05138042 | Breast Cancer F... | Cryotherapy (fr... | 20 Years - | Chung Shan Medical University | |
N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients | NCT03492047 | Peripheral Neur... | low dose N-acet... high dose N-ace... Paclitaxel | 18 Years - 85 Years | Ain Shams University | |
Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer | NCT05673746 | Peripheral Neur... | Acupuncture treatment of ph... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer | NCT02215083 | Peripheral Neur... | L-glutamine | 18 Years - | Eastern Regional Medical Center | |
Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy | NCT00380965 | Peripheral Neur... Antineoplastic ... | Cesamet™ (nabil... | 18 Years - 75 Years | NEMA Research, Inc. | |
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors | NCT05582551 | Childhood Cance... | Highlighting Pa... | 7 Years - 17 Years | Washington University School of Medicine | |
PT-112 in Subjects With Thymoma and Thymic Carcinoma | NCT05104736 | Thymic Epitheli... Recurrent Thymo... Thymic Cancer | PT-112 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | NCT01783522 | Chemotherapeuti... Multiple Myelom... Peripheral Neur... | glutamine quality-of-life... placebo | 18 Years - | Case Comprehensive Cancer Center | |
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | NCT02590367 | Peripheral Neur... | FOLFOX regimen HD6610 Granule HD6610 Granule ... | 18 Years - 70 Years | Jiangsu Province Hospital of Traditional Chinese Medicine | |
Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer | NCT05673746 | Peripheral Neur... | Acupuncture treatment of ph... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients | NCT05595109 | Breast Cancer Peripheral Neur... Cardiac Toxicit... Hepatic Toxicit... Cognitive Impai... | Silymarin Placebo | 18 Years - | Tanta University | |
L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients | NCT02808624 | Peripheral Neur... Cancer | L-CARNOSINE | 18 Years - 60 Years | Cairo University | |
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients | NCT01697839 | Multiple Myelom... Peripheral Neur... | 18 Years - | Oncotherapeutics | ||
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies | NCT02221700 | Malignant Breas... Malignant Diges... Peripheral Neur... | Massage Therapy Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors | NCT05378256 | Lymphoma Peripheral Neur... | Clinical scales... | 18 Years - | Centre Hospitalier Régional d'Orléans | |
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy | NCT00952848 | Chemotherapeuti... Neurotoxicity Pain Peripheral Neur... Unspecified Adu... | questionnaire a... Sensory Neuropa... Quality of Life... MC5-A Scrambler... | 18 Years - 120 Years | Virginia Commonwealth University | |
Chemotherapy - Induced Peripheral Neuropathy | NCT05138042 | Breast Cancer F... | Cryotherapy (fr... | 20 Years - | Chung Shan Medical University | |
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study) | NCT01278004 | Cancer Peripheral Neur... | Ethosuximide Placebo | 18 Years - | Royal Marsden NHS Foundation Trust | |
Yoga for Symptoms of Nerve Damage Caused by Chemotherapy | NCT03292328 | Breast Cancer Peripheral Neur... Gynecologic Can... | Yoga Wait List Contr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer | NCT02428101 | Gastrointestina... Peripheral Neur... | polymorphism an... | 18 Years - 80 Years | Ain Shams University | |
Acupuncture for Chemo-Induced Peripheral Neuropathy | NCT00891618 | Lymphoma Myeloma Peripheral Neur... | Acupuncture | 18 Years - | M.D. Anderson Cancer Center | |
Acupuncture for Symptoms of Nerve Damage | NCT03183037 | Peripheral Neur... Chemotherapy-in... | Acupuncture Sham Acupunctur... Usual Care Grou... questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study | NCT02744274 | Colorectal Canc... | Verum acupunctu... | 20 Years - 70 Years | China Medical University Hospital | |
Cryotherapy for Neuropathy in Children | NCT04536207 | Cancer | Cryotherapy (ap... | 8 Years - 17 Years | South Valley University | |
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | NCT01783522 | Chemotherapeuti... Multiple Myelom... Peripheral Neur... | glutamine quality-of-life... placebo | 18 Years - | Case Comprehensive Cancer Center | |
Cryotherapy & Oxaliplatin | NCT06281925 | Colon Cancer Peripheral Neur... | Cryotherapy Glo... | 18 Years - | NYU Langone Health | |
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel | NCT01243541 | Chemotherapeuti... Pain Peripheral Neur... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Therapy-related... | cryotherapy questionnaire a... quality-of-life... management of t... assessment of t... | 18 Years - | Northwestern University | |
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | NCT00058071 | Gestational Tro... Neurotoxicity Peripheral Neur... Unspecified Adu... | amifostine trih... | 18 Years - | GOG Foundation | |
Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy | NCT06400849 | Non-metastatic ... | cryotherapy alo... cryotherapy and... | 18 Years - 99 Years | Centre Antoine Lacassagne | |
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | NCT00489411 | Neurotoxicity Pain Peripheral Neur... Unspecified Adu... | duloxetine hydr... placebo | 25 Years - | Alliance for Clinical Trials in Oncology | |
Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer | NCT04461977 | Peripheral Neur... | True acupunctur... Sham acupunctur... | 18 Years - | Instituto Brasileiro de Controle do Cancer | |
Rood's Approach and Oxaliplatin-induced Peripheral Neuropathy in Colorectal Cancer Patients | NCT05882396 | Colorectal Canc... Peripheral Neur... | Rood's approach Traditional phy... | 18 Years - 60 Years | Cairo University | |
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients" | NCT05189535 | Breast Cancer F... Peripheral Neur... | Pentoxifylline Paclitaxel Placebo | 18 Years - 80 Years | Ain Shams University | |
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy | NCT01982591 | Male Breast Can... Neurotoxicity Peripheral Neur... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | laboratory biom... questionnaire a... | 18 Years - | Fox Chase Cancer Center | |
The Inland Northwest Colon Cancer Survivor's Study | NCT01775254 | Colon Cancer | 18 Years - | Washington State University | ||
Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy | NCT01313117 | Peripheral Neur... | Alpha lipoic ac... | 18 Years - | Northwestern University | |
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients | NCT05680870 | Chemotherapy In... | Omeprazole | 18 Years - 65 Years | Tanta University |